Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

NCT05092776 is registered in ClinicalTrials.gov with R-Pharm International, LLC as lead sponsor.

NCT NCT05092776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05092776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Lead sponsor
R-Pharm International, LLC
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 29, 2021
Completion date
October 30, 2025
Enrollment
84 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

familial mediterranean fever, fmf